TSX:MRE • CA5734591046
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for MARTINREA INTERNATIONAL INC (MRE.CA).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-12-07 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-12-07 | STA Research | Maintains | Hold |
| 2022-11-02 | Raymond James Capital | Upgrade | Outperform |
| 2022-11-02 | BMO Financial | Upgrade | |
| 2022-11-02 | TD Research | Maintains | Action List Buy |
| 2022-11-02 | CIBC Capital Markets | Upgrade | Neutral |
| 2022-11-02 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-11-02 | STA Research | Maintains | Hold |
| 2022-10-20 | CIBC Capital Markets | Downgrade | Strong Buy |
| 2022-09-29 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-09-29 | STA Research | Maintains | Hold |
| 2022-08-09 | Raymond James Capital | Upgrade | Market Perform |
| 2022-08-09 | BMO Financial | Upgrade | Outperform |
| 2022-08-09 | CIBC Capital Markets | Upgrade | Neutral |
| 2022-08-09 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-08-05 | TD Research | Downgrade | Action List Buy |
| 2022-06-03 | CIBC Capital Markets | Downgrade | Neutral |
| 2022-05-06 | Raymond James Capital | Initiate | Market Perform |
| 2022-05-06 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-05-06 | Scotiabank Capital | Upgrade | Sector Perform |
| 2022-04-25 | CIBC Capital Markets | Downgrade | Outperform |
| 2022-04-01 | Scotiabank Capital | Downgrade | Sector Perform |
| 2022-03-04 | Raymond James Capital | Downgrade | Market Perform |
| 2022-03-04 | BMO Financial | Downgrade | Outperform |
| 2022-03-04 | TD Research | Downgrade | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.758B 25.73% | 5.34B 12.24% | 5.014B -6.10% | 4.899B -2.30% | 5.026B 2.59% | 4.96B -1.31% | |
| EBITDA YoY % growth | 495.935M 66.64% | 616.678M 24.35% | 614.758M -0.31% | 595.5M -3.13% | 620.76M 4.24% | 646.27M 4.11% | |
| EBIT YoY % growth | 210.299M 325.75% | 296.236M 40.86% | 268.209M -9.46% | 273.04M 1.80% | 290.22M 6.29% | 314.46M 8.35% | |
| Operating Margin | 4.42% | 5.55% | 5.35% | 5.57% | 5.77% | 6.34% | |
| EPS YoY % growth | 1.77 321.43% | 2.21 24.86% | 1.18 -46.61% | 2.02 71.19% | 2.30 13.80% | 2.51 9.40% |
All data in CAD
| Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | 0.49 333.74% | 0.49 19.48% | 0.53 -19.66% | 0.54 2.94% | 0.52 4.94% |
| Revenue Q2Q % growth | 1.238B 7.57% | N/A | N/A | N/A | N/A |
| EBITDA Q2Q % growth | 152.78M -60.49% | 156.25M 10.88% | 164.13M -32.82% | 149.28M -49.99% | 142.11M -6.98% |
| EBIT Q2Q % growth | 64.982M 62.09% | N/A | N/A | N/A | N/A |
All data in CAD
9 analysts have analysed MRE.CA and the average price target is 13.01 CAD. This implies a price increase of 22.69% is expected in the next year compared to the current price of 10.6.
MARTINREA INTERNATIONAL INC (MRE.CA) will report earnings on 2026-04-29.
The consensus EPS estimate for the next earnings of MARTINREA INTERNATIONAL INC (MRE.CA) is 0.49 CAD and the consensus revenue estimate is 1.24B CAD.
The number of analysts covering MARTINREA INTERNATIONAL INC (MRE.CA) is 9.